Form 990 for tax year 2022
Filed by MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION.
Totals
- Total revenue
- $18,297,575
- Total expenses
- $28,681,699
- Contributions and grants received
- $19,131,206
- Grants paid
- $19,379,059
- Program service revenue
- $0
- Investment income
- -$926,435
- Other revenue
- $92,804
- Total assets, end of year
- $78,560,475
- Total liabilities, end of year
- $9,303,185
- Net assets or fund balances, end of year
- $69,257,290
- Program services expenses (Part IX)
- $23,042,415
- Management and general expenses
- $2,406,628
- Fundraising expenses
- $3,232,656
- Program service expenses (Part III)
- $23,042,415
Program services were 80.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$4,547,024
-
1f · All other contributions, gifts and grants
$14,584,182
-
1g · Noncash contributions included above
$1,825,156
-
3 · Investment income
total $1,507,003 · excluded $1,507,003
-
5 · Royalties
total $92,804 · excluded $92,804
-
7a · Gross sales of assets other than inventory
securities $25,397,338
-
7b · Less cost or other basis and sales expenses
securities $27,830,776
-
7c · Gain or loss
securities -$2,433,438
-
7d · Net gain or loss
total -$2,433,438 · excluded -$2,433,438
-
8a · Fundraising events: gross income
$160,156
-
8a · Fundraising events: contributions included on line 1c
$4,547,024
-
8b · Fundraising events: direct expenses
$160,156
-
8c · Net income from fundraising events
total $0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $18,807,587 · program services $18,807,587
-
3 · Grants to foreign organizations and individuals
total $571,472 · program services $571,472
-
5 · Compensation of officers, directors and key employees
total $1,074,957 · program services $375,636 · management and general $554,099 · fundraising $145,222
-
7 · Other salaries and wages
total $2,774,481 · program services $1,135,552 · management and general $653,418 · fundraising $985,511
-
8 · Pension plan contributions
total $108,489 · program services $44,918 · management and general $30,202 · fundraising $33,369
-
9 · Other employee benefits
total $400,156 · program services $155,488 · management and general $128,597 · fundraising $116,071
-
10 · Payroll taxes
total $302,376 · program services $124,942 · management and general $88,546 · fundraising $88,888
-
11e · Fees: professional fundraising services
total $53,522 · fundraising $53,522
-
11f · Fees: investment management
total $307,276 · management and general $307,276
-
11g · Fees: other
total $823,860 · program services $438,691 · management and general $131,607 · fundraising $253,562
-
12 · Advertising and promotion
total $922,479 · program services $276,744 · management and general $92,248 · fundraising $553,487
-
14 · Information technology
total $458,715 · program services $183,486 · management and general $114,679 · fundraising $160,550
-
16 · Occupancy
total $240,053 · program services $95,754 · management and general $60,516 · fundraising $83,783
-
19 · Conferences, conventions and meetings
total $58,356 · program services $14,589 · management and general $8,753 · fundraising $35,014
-
22 · Depreciation, depletion and amortization
total $90,648 · program services $36,259 · management and general $22,662 · fundraising $31,727
-
23 · Insurance
total $44,061 · program services $17,625 · management and general $11,015 · fundraising $15,421
-
24a · Other expenses: DIRECT MAIL DESIGN & PR
total $1,302,524 · program services $651,263 · management and general $195,378 · fundraising $455,883
-
24b · Other expenses: BANK & CREDIT CARD FEES
total $228,278 · management and general $7,632 · fundraising $220,646
-
24c · Other expenses: RESEARCH SUPPORT
total $112,409 · program services $112,409
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $2,308,831 · end of year $3,731,289
-
3 · Pledges and grants receivable
beginning of year $1,982,801 · end of year $1,440,671
-
8 · Inventories for sale or use
beginning of year $1,234
-
9 · Prepaid expenses and deferred charges
beginning of year $211,815 · end of year $190,010
-
10a · Land, buildings and equipment: cost or other basis
$388,811
-
10b · Land, buildings and equipment: accumulated depreciation
$284,264
-
10c · Land, buildings and equipment, net
beginning of year $195,195 · end of year $104,547
-
11 · Investments: publicly traded securities
beginning of year $73,805,521 · end of year $72,170,913
-
15 · Other assets
beginning of year $0 · end of year $923,045
-
17 · Accounts payable and accrued expenses
beginning of year $760,077 · end of year $889,012
-
18 · Grants payable
beginning of year $7,629,947 · end of year $7,382,067
-
19 · Deferred revenue
end of year $30,000
-
25 · Other liabilities
beginning of year $83,740 · end of year $1,002,106
-
27 · Net assets without donor restrictions
beginning of year $68,371,633 · end of year $68,173,573
-
28 · Net assets with donor restrictions
beginning of year $1,660,000 · end of year $1,083,717
Mission and programs · 2022
Mission
THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD. SEE SCHEDULE O.THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS, TRANSFORMING PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. 100% OF ALL DONATIONS FUEL THE RESEARCH TO ADVANCE UNDERSTANDING OF THIS COMPLEX, DEVASTATING AND UNDERFUNDED CANCER.
Activities or mission (Part I)
THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD.THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD. THE FOUNDATION'S MISSION IS TO CURE PANCREATIC CANCER BY FUNDING SCIENTIFIC AND CLINICAL RESEARCH RELATED TO THE DIAGNOSIS, TREATMENT AND PREVENTION OF PANCREATIC CANCER; PROVIDING RESEARCH INFORMATION AND CLINICAL SUPPORT SERVICES TO PATIENTS, CAREGIVERS AND INDIVIDUALS AT HIGH RISK; AND INCREASING PUBLIC AWARENESS AND HOPE FOR THOSE DEALING WITH THIS DISEASE. SINCE ITS INCEPTION, THE LUSTGARTEN FOUNDATION HAS DIRECTED MORE THAN $250 MILLION TO RESEARCH AND HAS ASSEMBLED THE BEST SCIENTIFIC MINDS WITH THE HOPE THAT ONE DAY, A CURE CAN BE FOUND.
-
RESEARCH PROGRAM: THE LUSTGARTEN FOUNDATION'S MISSION IS TO ADVANCE THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. 2023 MARKED THE FOUNDATION'S 25TH ANNIVERSARY OF DRIVING PIONEERING PANCREATIC CANCER RESEARCH BREAKTHROUGHS, ACCELERATING PROGRESS FASTER THAN EVER BEFORE AND PROVIDING A MORE HOPEFUL FUTURE FOR ALL PATIENTS. SEE SCHEDULE O.
Expenses $20,863,817 · Grants $19,379,059
-
PUBLIC EDUCATION AND INFORMATION PROGRAM: THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS, AND TRANSFORMING PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS, AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. 100% OF ALL DONATIONS FUEL THE RESEARCH TO ADVANCE UNDERSTANDING OF THIS COMPLEX, DEVASTATING AND UNDERFUNDED CANCER. SEE SCHEDULE O.
Expenses $1,374,374
-
PROFESSIONAL EDUCATION PROGRAM: PROFESSIONAL EDUCATION FOCUSED ON THE FOUNDATION'S SENIOR LEADERSHIP CONDUCTING HIGH-LEVEL MEETINGS WITH FUNDED SCIENTISTS AND DIRECTORS OF THE LABS PROGRAM SITES AND COLLABORATING ORGANIZATIONS, AS WELL AS ATTENDING/PRESENTING AT SCIENTIFIC MEETINGS FOR ORGANIZATIONS INCLUDING THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) AND STAND UP TO CANCER (SU2C). SEE SCHEDULE O.
Expenses $804,224
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Andrew LustgartenANDREW LUSTGARTEN
CHAIRMAN
- Total calculated
- $0
- Hours/week
- 2
-
James L DolanJAMES L DOLAN
VICE CHAIRMAN
- Total calculated
- $0
- Hours/week
- 2
-
Adam SilverADAM SILVER
VICE CHAIRMAN
- Total calculated
- $0
- Hours/week
- 2
-
Jennie FortunoffJENNIE FORTUNOFF
SECRETARY
- Total calculated
- $0
- Hours/week
- 2
-
Philip D'AmbrosioPHILIP D'AMBROSIO
TREASURER
- Total calculated
- $0
- Hours/week
- 2
-
William BellWILLIAM BELL
TREASURER/DIRECTOR (END 10/27/22)
- Total calculated
- $0
- Hours/week
- 2
-
Charles F DolanCHARLES F DOLAN
CHAIRMAN EMERITUS
- Total calculated
- $0
- Hours/week
- 2
-
Robert F VizzaROBERT F VIZZA
CHAIRMAN EMERITUS
- Total calculated
- $0
- Hours/week
- 2
-
Sommer Bazuro PhDSOMMER BAZURO PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
John H CobbJOHN H COBB
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Jessica Lustgarten CourtemancheJESSICA LUSTGARTEN COURTEMANCHE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Quentin F DolanQUENTIN F DOLAN
TRUSTEE
- Total calculated
- $0
- Hours/week
- 2
-
Kenneth Goodman MD FacrKENNETH GOODMAN MD FACR
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Marcia LustgartenMARCIA LUSTGARTEN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Sheila MahonySHEILA MAHONY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Charles R SchuelerCHARLES R SCHUELER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Willa ShalitWILLA SHALIT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Selwyn M VickersSELWYN M VICKERS
DIRECTOR (AS OF 6/15/2023)
- Total calculated
- $0
- Hours/week
- 2
-
Scott PenberthySCOTT PENBERTHY
DIRECTOR (AS OF 6/15/2023)
- Total calculated
- $0
- Hours/week
- 2
-
Linda TantawiLINDA TANTAWI
CEO
- Total calculated
- $460,101
- From this org
- $430,564
- From related orgs
- $0
- Other
- $29,537
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $316,814
- Bonus
- $113,750
- Other
- $0
- Deferred
- $8,100
- Nontaxable benefits
- $21,437
- Filer's total
- $460,101
-
Kerri KaplanKERRI KAPLAN
PRESIDENT
- Total calculated
- $347,675
- From this org
- $330,102
- From related orgs
- $0
- Other
- $17,573
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $262,247
- Bonus
- $67,855
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $17,573
- Filer's total
- $347,675
-
Faisal JawaidFAISAL JAWAID
CFO
- Total calculated
- $200,386
- From this org
- $197,906
- From related orgs
- $0
- Other
- $2,480
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $176,031
- Bonus
- $21,875
- Other
- $0
- Deferred
- $2,262
- Nontaxable benefits
- $218
- Filer's total
- $200,386
-
Andrew RakemanANDREW RAKEMAN
VP RESEARCH
- Total calculated
- $274,049
- From this org
- $248,673
- From related orgs
- $0
- Other
- $25,376
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $205,673
- Bonus
- $43,000
- Other
- $0
- Deferred
- $4,300
- Nontaxable benefits
- $21,076
- Filer's total
- $274,049
-
Glen PeckGLEN PECK
SVP TECHNOLOGY & BUSINESS INTELLIGENCE
- Total calculated
- $288,287
- From this org
- $262,312
- From related orgs
- $0
- Other
- $25,975
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $216,912
- Bonus
- $45,400
- Other
- $0
- Deferred
- $4,540
- Nontaxable benefits
- $21,435
- Filer's total
- $288,287
-
Stephanie DergarabedianSTEPHANIE DERGARABEDIAN
NATIONAL DIRECTOR OF DEVELOPMENT
- Total calculated
- $168,395
- From this org
- $148,385
- From related orgs
- $0
- Other
- $20,010
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $132,185
- Bonus
- $16,200
- Other
- $0
- Deferred
- $2,700
- Nontaxable benefits
- $17,310
- Filer's total
- $168,395
-
Susan M JacobsonSUSAN M JACOBSON
DIRECTOR EXTERNAL & COMMUNITY RELATIONS
- Total calculated
- $140,621
- From this org
- $130,890
- From related orgs
- $0
- Other
- $9,731
- Hours/week
- 40
-
Peter S CasalinoPETER S CASALINO
DIRECTOR DATA SERVICES
- Total calculated
- $124,192
- From this org
- $105,037
- From related orgs
- $0
- Other
- $19,155
- Hours/week
- 40
-
Catherine WeberCATHERINE WEBER
VP DEV OPS & CONST SVCS (END 7/31/22)
- Total calculated
- $389,986
- From this org
- $371,741
- From related orgs
- $0
- Other
- $18,245
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $147,126
- Bonus
- $40,000
- Other
- $184,615
- Deferred
- $4,000
- Nontaxable benefits
- $14,245
- Filer's total
- $389,986
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Form 990 of other organizations
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 7 · Other non-fixed payments
Answered no
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINES 4A-B
- LINE 4A - SEVERANCE COMPENSATION CATHERINE WEBER, VICE PRESIDENT OF DEVELOPMENT OPERATIONS & CONSITUENT SERVICES, RECEIVED A SEVERANCE PAYMENT OF $184,615 IN CALENDAR YEAR 2022. LINE 4B - SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN LINDA TANTAWI, CEO, PARTICIPATES IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN, AND $1,600 OF DEFERRED COMPENSATION RELATED TO THE PLAN IS REPORTED ON SCHEDULE J, PART II, COLUMN (C).
- PART I, LINE 7
- NONFIXED PAYMENTS IN 2022, OFFICERS AND EMPLOYEES RECEIVED NONFIXED DISCRETIONARY BONUSES AS REPORTED ON SCHEDULE J, PART II, COLUMN (B)(II).
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$5,726,518
PANCREATIC CANCER RESEARCH
-
$2,472,272
PANCREATIC CANCER RESEARCH
-
$2,161,911
PANCREATIC CANCER RESEARCH
-
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
$1,575,933
PANCREATIC CANCER RESEARCH
-
PANCREATIC CANCER RESEARCH
-
THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
$1,000,000
PANCREATIC CANCER RESEARCH
-
PANCREATIC CANCER RESEARCH
-
PANCREATIC CANCER RESEARCH
-
NYU GROSSMAN SCHOOL OF MEDICINE
$731,815
PANCREATIC CANCER RESEARCH
-
MASSACHUSETTES GENERAL HOSPITAL
$500,000
PANCREATIC CANCER RESEARCH
The 10 largest by cash amount. The API serves every itemized grant.
Fundraising and gaming
From Schedule G of this return, as filed.
- Raised funds through (line 1)
- mail, email, in person, non-government grants, special fundraising events
- Had an agreement with a professional fundraiser (line 2a)
- Yes
- Registered or licensed to solicit in (line 3)
- AL, AR, CA, CO, CT, FL, GA, HI, IL, KS, KY, ME, MD, MA, MI, MN, MO, NV, NH, NJ, NM, NY, NC, OH, OK, OR, PA, SC, TN, UT, VA, WA, WV, WI
Professional fundraisers (line 2b)
Their names and addresses are not shown.
| Activity | Custody of contributions | Gross receipts | Kept by fundraiser | To the organization |
|---|---|---|---|---|
| EVENT CONSULTING | No | $758,252 | $53,522 | $704,730 |
| Total, as filed | $758,252 | $53,522 | $704,730 | |
Fundraising events (Part II)
Part II has at most four columns: the two largest events, the rest together, and the total.
| Line | Event 1 BASH | Event 2 LI WALK | Other events 106 events | Total |
|---|---|---|---|---|
| Gross receipts (line 1) | $761,452 | $703,371 | $3,242,357 | $4,707,180 |
| Less contributions (line 2) | $601,296 | $703,371 | $3,242,357 | $4,547,024 |
| Gross income (line 3) | $160,156 | — | — | $160,156 |
| Cash prizes (line 4) | — | — | — | — |
| Noncash prizes (line 5) | — | — | — | — |
| Rent and facility costs (line 6) | — | — | — | — |
| Food and beverages (line 7) | $141,176 | — | — | $141,176 |
| Entertainment (line 8) | $3,107 | — | — | $3,107 |
| Other direct expenses (line 9) | $15,873 | — | — | $15,873 |
- Direct expenses (line 10)
- $160,156
- Net income (line 11)
- $0
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $571,472
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| NORTH AMERICA | 0 | 0 | GRANTMAKING | PANCREATIC CANCER RESEARCH | $399,905 |
| EUROPE | 0 | 0 | GRANTMAKING | PANCREATIC CANCER RESEARCH | $171,567 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| NORTH AMERICA | $399,905 | WIRE/EFT | $0 | — | — |
| EUROPE | $171,567 | WIRE/EFT | $0 | — | — |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- 2
- Other grantees (Part II line 3)
- 0
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 12 February 2024
- IRS schema version
- 2022v5.0
- Source object
- 202430449349301853
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.